DJIA 15,303.10 8.60 0.06%
NASDAQ 3,459.14 -0.28 -0.01%
S&P 500 1,649.60 -0.91 -0.06%

Amgen, Inc.

NASDAQ: AMGN


company name or ticker
Company Photos
(Click to zoom)

S&P Highlights Biotech ETFs

Amgen Forms China Joint Venture

Amgen Forms China Joint Venture With Zhejiang Beta Pharma

Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China

Why NPS Pharmaceuticals Is Up After Earnings

Orphan drugmaker NPS Pharmaceuticals reveals the progress of its Gattex launch.

Amgen, Inc. (AMGN): Today's Most Compelling Stock Buy

Recent Noteworthy Institutional 5% Ownership Filings In Healthcare Sector

Closing Bell for Wednesday on Wall Street: Markets Open Lower, Stock Prices Rise All Day

3 Hallmarks of a Megablockbuster

Everyone loves a drug with blockbuster potential. But why stop there? Here's a quick guide on how to find a megablockbuster, courtesy of three wildly successful drugs.

Amgen Trial of Colon Cancer Drug Meets Goal

See More Articles...